• ქართული
  • English
  • Takeda gets key U.S. regulatory approval to buy Shire

    Japan’s Takeda Pharmaceutical Co Ltd said on Tuesday it received a key U.S. regulatory approval for its $62 billion deal to buy London-listed Shire Plc.

    Market Quotes by TradingView